|
|
1.
|
A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design. MedStar authors:
Year: 2016
Citation: - American Heart Journal. 177:66-73, 2016 Jul
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Alvaro G, Amantea B, Auci E, Auriemma S, Baiocchi M, Bianchi A, Biondi-Zoccai G, Bove T, Bradic N, Buscaglia G, Calabro MG, Cariello C, Corcione A, De Vuono G, Fominskiy E, Frontini M, Galdieri N, Gemma M, Gianni S, Grigoryev E, Guarracino F, Landoni G, Lembo R, Likhvantsev V, Lipinski MJ, Lobreglio R, Lomivorotov VV, Monaco F, Pala G, Paternoster G, Pisano A, Sangalli F, Wang CY, Zangrillo A, Zucchetti MC
|
|
|
2.
|
Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction. MedStar authors:
Year: 2020
Citation: - Journal of the American Heart Association. 9(5):e014941, 2020 03 03.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Abbate A, Abouzaki N, Appleton D, Biondi-Zoccai GG, Bressi E, Buckley LF, Canada JM, Carbone S, Chiabrando JG, Christopher S, Del Buono MG, Dixon DL, Garnett J, Kadariya D, Kontos MC, Lipinski MJ, Markley R, Medina de Chazal H, Melchior R, Mueller G, Puckett L, Roberts CS, Schatz A, Thomas C, Trankle CR, Turlington J, Van Tassell BW, Vo C, Wohlford GF
|
